Dr. Adil S. Wakil, MD

Dr. Wakil practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Wakil's NPI, 1043237712, was assigned on July 17, 2006. Dr. Wakil graduated from UT Southwestern Medical Center in 1988. Dr. Wakil's California license number on file is 482387.

Dr. Wakil's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Wakil's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Wakil is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Wakil to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wakil practices, 7 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Wakil's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Wakil is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Wakil's licenses on file in 3 states: California, Nevada and Texas.

Dmand AI lists acid reflux, cirrhosis of the liver, fatty liver, liver disease and upper GI endoscopy among the conditions Dr. Wakil treats.

CMS data shows 588 Medicare services from Dr. Wakil across 7 procedure codes in 2024, for 293 Medicare patients. Medicare paid $67,913 for them.

CMS counts 293 Medicare patients who saw Dr. Wakil in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wakil's median patient age at 64, with 42% women.

In 2024, Dr. Wakil wrote 1,200 Medicare Part D claims for 164 patients. 81% of them were for generic drugs. CMS names the drug for 967 of them, across 24 drugs with 11 or more claims each, at $564,144 in total drug cost. In 2023, CMS named 985 claims across 21 drugs.

Dr. Wakil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wakil as offering telehealth. CMS counts 14 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Wakil, more than 45% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Wakil, published from 2007 to 2011. The most frequent topics are Interleukin-4, Leishmania major and Leishmaniasis, Cutaneous. Dr. Wakil has published most often in Science. Dr. Wakil's most frequent co-authors are Natalie Bzowej, MD, Robert Gareth Gish, MD and Maurizio Bonacini, MD.

CMS Open Payments shows 1 general payment to Dr. Wakil from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $96.

Dmand AI lists 1 award for Dr. Wakil, most recently Regional Top Doctor in 2014.

Dr. Wakil graduated from UT Southwestern Medical Center in 1988.

Dr. Wakil is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.